Du C, Wang X, Zhang J, Liu X, Zhu J, Liu Y. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells. Oncol Rep. 2016 Jan;35(1):409–17. doi: 10.3892/or.2015.4352. PMID: 26530439.
Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells